[Seite 48↓]


1. Lanza RP, Langer R. Vacanti JP. Principles of Tissue Engineering, Second Edition.

2. Vacanti CA, Vacanti JP. History and Scope of Tissue Engineering; Lanza RP, Langer R. Vacanti JP; Principles of Tissue Engineering, Second Edition.

3. Hume DM, Merrill JP, Miller BF, Thorn GW. Experiences with renal homotransplantation in the human: report of nine cases. J Clin Invest. 1955 Feb; 34(2): 327-82.

4. Starzl TE, Marchioro TL, Huntley RT, Rifkind D, Rowlands DT Jr, Dickinson TC, Waddell WR. EXPERIMENTAL AND CLINICAL HOMOTRANSPLANTATION OF THE LIVER. Ann N Y Acad Sci. 1964 Nov 30; 120: 739-65.

5. Dong E Jr, Lower RR, Hurley EJ, Shumway NE. Transplantation of the heart. Dis Chest. 1965 Nov; 48(5): 455-7.

6. Hetzer R, Loebe M, Potapov EV, Wenig Y, Stiller B, Hennig E, Alexi-Meskishvili V, Lange PE. Circulatory support with pneumatic paracorporeal ventricular assist device in infants and children. Ann Thorac Surg. 1998 Nov; 66(5): 1498-506.

7. Penn I. Occurrence of cancers in immunosuppressed organ transplant recipients. Clin Transpl. 1998; : 147-58.

8. Edwards LB, Keck BM. Thoracic organ transplantation in the US. Clin Transpl. 2002; : 29-40.

9. Williams WG, McCrindle BW, Ashburn DA, Jonas RA, Mavroudis C, Blackstone EH; Congenital Heart Surgeon’s Society. Outcomes of 829 neonates with complete transposition of the great arteries 12-17 years after repair. Eur J Cardiothorac Surg. 2003 Jul; 24(1): 1-9; discussion 9-10.

10. .Sullivan JM, Harken DE, Gorlin R. Pharmacologic control of thromboembolic complications of cardiac-valve replacement. A preliminary report. N Engl J Med. 1968 Sep 12; 279(11): 576-80.

11. Cannegieter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses. Circulation. 1994 Feb; 89(2): 635-41.

12. Hammermeister K, Sethi GK, Henderson WG, Grover FL, Oprian C, Rahimtoola SH. Outcomes 15 years after valve replacement with a mechanical versus a bioprosthetic valve: final report of the Veterans Affairs. A randomized trial. J Am Coll Cardiol. 2000 Oct; 36(4): 1152-8.

[Seite 49↓]

13. Yankah AC, Alexi-Meskhishvili V, Wenig Y, Berger F, Lange P, Hetzer R. Performance of aortic and pulmonary homografts in the right ventricular outflow tract in children. J Heart Valve Dis. 1995 Jul; 4(4): 392-5.

14. Brown JW, Ruzmetov M, Vijay P, Rodefeld MD, Turrentine MW. Surgery for aortic stenosis in children: a 40-year experience. Ann Thorac Surg. 2003 Nov; 76(5): 1398-411.

15. Erez E, Kanter KR, Isom E, Williams WH, Tam VK. Mitral valve replacement in children. J Heart Valve Dis. 2003 Jan; 12(1): 25-9; discussion 30.

16. Raghuveer G, Caldarone CA, Hills CB, Atkins DL, Belmont JM, Moller JH. Predictors of prosthesis survival, growth, and functional status following mechanical mitral valve replacement in children aged <5 years, a multi-institutional study. Circulation. 2003 Sep 9; 108 Suppl 1: II174-9.

17. Riles TS. Presidential address: the next quarter. J Vasc Surg. 2004 Feb; 39(2): 275-8.

18. Dieval F, Chakfe N, Wang L, Riepe G, Thaveau F, Heintz C, Mathieu D, Le Magnen JF, Kretz JG, Durand B; European Group for Research into Vascular Grafts. Mechanisms of rupture of knitted polyester vascular prostheses: an in vitro analysis of virgin prostheses. Eur J Vasc Endovasc Surg. 2003 Oct; 26(4): 429-36.

19. Haruguchi H, Teraoka S. Intimal hyperplasia and hemodynamic factors in arterial bypass and arteriovenous grafts: a review. J Artif Organs. 2003; 6(4): 227-35. Review.

20. Kadoba K, Schoen FJ, Jonas RA. Experimental comparison of albumin-sealed and gelatin-sealed knitted Dacron conduits. Porosity control, handling, sealant resorption, and healing. J Thorac Cardiovasc Surg. 1992 Jun; 103(6): 1059-67.

21. Langer RS, Vacanti JP. Tissue engineering: the challenges ahead. Sci Am. 1999 Apr; 280(4): 86-9.

22. Vacanti CA, Vacanti JP. The science of tissue engineering. Orthop Clin North Am. 2000 Jul; 31(3): 351-6.

23. Vacanti JP. Tissue and organ engineering: can we build intestine and vital organs? J Gastrointest Surg. 2003 Nov; 7(7): 831-5.

24. Nerem RM. The challenge of imitating nature; Lanza RP, Langer R. Vacanti JP; Principles of Tissue Engineering, Second Edition.

25. Matas AJ, Sutherland DE, Steffes MW, Simmons RL, Najarian JS. Hepatocellular transplantation in UDP-glucuronyl-transferase-deficient rats. Surg Forum. 1975; 26: 428-31.

[Seite 50↓]

26. Sullivan SJ, Lanza RP, Maki T, Borland KM, Lodge JP, Staruk JE, Muller TE, Monaco AP, Solomon BA, Chick W. Islet transplantation using an immunoprotective membrane in dogs that have undergone a pancreatectomy. ASAIO J. 1992 Jul-Sep; 38(3): M450-3.

27. Gerlach JC, Mutig K, Sauer IM, Schrade P, Efimova E, Mieder T, Naumann G, Grunwald A, Pless G, Mas A, Bachmann S, Neuhaus P, Zeilinger K. Use of primary human liver cells originating from discarded grafts in a bioreactor for liver support therapy and the prospects of culturing adult liver stem cells in bioreactors: a morphologic study. Transplantation. 2003 Sep 15; 76(5): 781-6.

28. Jaeger CB, Greene LA, Tresco PA, Winn SR, Aebischer P. Polymer encapsulated dopaminergic cell lines as "alternative neural grafts". Prog Brain Res. 1990; 82: 41-6.

29. Monaco AP, Maki T, Ozato H, Carretta M, Sullivan SJ, Borland KM, Mahoney MD, Chick WL, Muller TE, Wolfrum J et al. Transplantation of islet allografts and xenografts in totally pancreatectomized diabetic dogs using the hybrid artificial pancreas. Ann Surg. 1991 Sep; 214(3): 339-60; discussion 361-2.

30. Shieh SJ, Terada S, Vacanti JP. Tissue engineering auricular reconstruction: in vitro and in vivo studies. Biomaterials. 2004 Apr; 25(9): 1545-57.

31. Gardner-Thorpe J, Grikscheit TC, Ito H, Perez A, Ashley SW, Vacanti JP, Whang EE. Angiogenesis in tissue-engineered small intestine. Tissue Eng. 2003 Dec; 9(6): 1255-61.

32. Zund G, Breuer CK, Shinoka T, Ma PX, Langer R, Mayer JE, Vacanti JP. The in vitro construction of a tissue engineered bioprosthetic heart valve. Eur J Cardiothorac Surg. 1997 Mar; 11(3): 493-7.

33. Shinoka T, Ma PX, Shum-Tim D, Breuer CK, Cusick RA, Zund G, Langer R, Vacanti JP, Mayer JE Jr. Tissue-engineered heart valves. Autologous valve leaflet replacement study in a lamb model. Circulation. 1996 Nov 1; 94(9 Suppl): II164-8.

34. Kaushal S, Amiel GE, Guleserian KJ, Shapira OM, Perry T, Sutherland FW, Rabkin E, Moran AM, Schoen FJ, Atala A, Soker S, Bischoff J, Mayer JE Jr. Functional small-diameter neovessels created using endothelial progenitor cells expanded ex vivo. Nat Med. 2001 Sep; 7(9): 1035-40.

35. Lovell MJ, Mathur A. The role of stem cells for treatment of cardiovascular disease. Cell Prolif. 2004 Feb; 37(1): 67-87.

36. Waksman R, Baffour R. Bone marrow and bone marrow derived mononuclear stem cells therapy for the chronically ischemic myocardium. Cardiovasc Radiat Med. 2003 Jul-Sep; 4(3): 164-8.

[Seite 51↓]

37. Rabkin E, Schoen FJ. Cardiovascular tissue engineering. Cardiovasc Pathol. 2002 Nov-Dec; 11(6): 305-17.

38. van Bilsen PH, Popa ER, Brouwer LA, Vincent J, Taylor CE, de Leij LF, Hendriks M, van Luyn MJ. Ongoing foreign body reaction to subcutaneous implanted (heparin) modified Dacron in rats. J Biomed Mater Res. 2004 Mar 1; 68A(3): 423-7.

39. Trubel W, Schima H, Czerny M, Perktold K, Schimek MG, Polterauer P. Experimental comparison of four methods of end-to-side anastomosis with expanded polytetrafluoroethylene. Br J Surg. 2004 Feb; 91(2): 159-67.

40. Veiseh M, Wickes BT, Castner DG, Zhang M. Guided cell patterning on gold-silicon dioxide substrates by surface molecular engineering. Biomaterials. 2004 Jul; 25(16): 3315-24.

41. Williams SF, Martin DP, Horowitz DM, Peoples OP. PHA applications: addressing the price performance issue: I. Tissue engineering. Int J Biol Macromol. 1999 Jun-Jul; 25(1-3): 111-21.

42. Marlovits S, Tichy B, Truppe M, Gruber D, Vecsei V. Chondrogenesis of aged human articular cartilage in a scaffold-free bioreactor. Tissue Eng. 2003 Dec; 9(6): 1215-26.

43. Meinel L, Karageorgiou V, Fajardo R, Snyder B, Shinde-Patil V, Zichner L, Kaplan D, Langer R, Vunjak-Novakovic G. Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng. 2004 Jan; 32(1): 112-22.

44. Christensen R, Jensen UB, Jensen TG. Skin genetically engineered as a bioreactor or a 'metabolic sink'. Cells Tissues Organs. 2002; 172(2): 96-104.

45. Shinoka T, Breuer CK, Tanel RE, Zund G, Miura T, Ma PX, Langer R, Vacanti JP, Mayer JE Jr. Tissue engineering heart valves: valve leaflet replacement study in a lamb model. Ann Thorac Surg. 1995 Dec; 60(6 Suppl): S513-6.

46. Bader A, Schilling T, Teebken OE, Brandes G, Herden T, Steinhoff G, Haverich A. Tissue engineering of heart valves--human endothelial cell seeding of detergent acellularized porcine valves. Eur J Cardiothorac Surg. 1998 Sep; 14(3): 279-84.

47. Simon P, Kasimir MT, Seebacher G, Weigel G, Ullrich R, Salzer-Muhar U, Rieder E, Wolner E. Early failure of the tissue engineered porcine heart valve SYNERGRAFT in pediatric patients. Eur J Cardiothorac Surg. 2003 Jun; 23(6): 1002-6; discussion 1006.

48. Weinberg CB, Bell E. A blood vessel model constructed from collagen and cultured vascular cells. Science. 1986 Jan 24; 231(4736): 397-400.

[Seite 52↓]

49. L'Heureux N, Stoclet JC, Auger FA, Lagaud GJ, Germain L, Andriantsitohaina R. A human tissue-engineered vascular media: a new model for pharmacological studies of contractile responses. FASEB J. 2001 Feb; 15(2): 515-24.

50. Niklason LE, Gao J, Abbott WM, Hirschi KK, Houser S, Marini R, Langer R. Functional arteries grown in vitro. Science. 1999 Apr 16; 284(5413): 489-93.

51. Shin’oka T, Imai Y, Ikada Y. Transplantation of a tissue engineered pulmonary artery. N Engl J Med 2001; 344: 532-33.

52. Laube HR, Duwe J, Rutsch W, Konertz W. Clinical experience with autologous endothelial cell-seeded polytetrafluoroethylene coronary artery bypass grafts. J Thorac Cardiovasc Surg. 2000 Jul; 120(1): 134-41.

53. Papadaki M, Bursac N, Langer R, Merok J, Vunjak-Novakovic G, Freed LE. Tissue engineering of functional cardiac muscle: molecular, structural, and electrophysiological study. Am J Physiol Heart Circ Physiol. 2001 Jan; 280(1): H168-78.

54. Menasche P. Myoblast-based cell transplantation. Heart Fail Rev. 2003 Jul; 8(3): 221-7.

55. Stamm C, Westphal B, Kleine HD, Petzsch M, Kittner C, Klinge H, Schumichen C, Nienaber CA, Freund M, Steinhoff G. Autologous bone-marrow stem-cell transplantation for myocardial regeneration. Lancet. 2003 Jan 4; 361(9351): 45-6.

56. Brenner W, Aicher A, Eckey T, Massoudi S, Zuhayra M, Koehl U, Heeschen C, Kampen WU, Zeiher AM, Dimmeler S, Henze E. 111In-Labeled CD34+ Hematopoietic Progenitor Cells in a Rat Myocardial Infarction Model. J Nucl Med. 2004 Mar; 45(3): 512-518.

57. Niklason LE, Langer RS. Advances in tissue engineering of blood vessels and other tissues. Transpl Immunol. 1997 Dec; 5(4): 303-6.

58. Cancedda R, De Luca M. Tissue engineering for clinical application. Year Immunol. 1993; 7: 193-8. Review.

59. Williams SF, Peoples OP. Biodegradable plastics from plants. Chemtech 26: 38-44, 1996.

60. Stock UA, Nagashima M, Khalil PN, Nollert GD, Herden T, Sperling JS, Moran A, Lien J, Martin DP, Schoen FJ, Vacanti, JP, Mayer JE Jr. Tissue-engineered valved conduits in the pulmonary circulation. J Thorac Cardiovasc Surg. 2000 Apr; 119(4 Pt 1): 732-40.

61. Zund G, Breuer CK, Shinoka T, Ma PX, Langer R, Mayer JE, Vacanti JP. The in vitro construction of a tissue engineered bioprosthetic heart valves. Eur J Cardiothorac Surg. 1997 Mar; 11(3): 493-7.

[Seite 53↓]

62. Mitsumata M, Fishel RS, Nerem RM, Alexander RW, Berk BC. Fluid shear stress stimulates platelet-derived growth factor expression in endothelial cells. Am J Physiol. 1993 Jul; 265(1 Pt 2): H3-8.

63. Kanda K, Matsuda T. Mechanical stress-induced orientation and ultrastructural change of smooth muscle cells cultured in three-dimensional collagen lattices. Cell Transplant. 1994 Nov-Dec; 3(6): 481-92.

64. Benbrahim A, L'Italien GJ, Milinazzo BB, Warnock DF, Dhara S, Gertler JP, Orkin RW, Abbott WM. A compliant tubular device to study the influences of wall strain and fluid shear stress on cells of the vascular wall. J Vasc Surg. 1994 Aug; 20(2): 184-94.

65. Ye Q, Zund G, Jockenhoevel S, Hoerstrup SP, Schoeberlein A, Grunenfelder J, Turina M. Tissue engineering in cardiovascular surgery: new approach to develop completely human autologous tissue. Eur J Cardiothorac Surg. 2000 Apr; 17(4): 449-54.

66. Hoerstrup SP, Zund G, Sodian R, Schnell AM, Grunenfelder J, Turina MI. Tissue engineering of small caliber vascular grafts. Eur J Cardiothorac Surg. 2001 Jul; 20(1): 164-9.

67. Hoerstrup SP, Kadner A, Melnitchouk S, Trojan A, Eid K, Tracy J, Sodian R, Visjager JF, Kolb SA, Grunenfelder J, Zund G, Turina MI. Tissue engineering of functional trileaflet heart valves from human marrow stromal cells. Circulation. 2002 Sep 24; 106(12 Suppl 1): I143-50.

68. Hoerstrup SP, Kadner A, Breymann C, Maurus CF, Guenter CI, Sodian R, Visjager JF, Zund G, Turina MI. Living, autologous pulmonary artery conduits tissue engineered from human umbilical cord cells. Ann Thorac Surg. 2002 Jul; 74(1): 46-52; discussion 52.

69. Hoerstrup SP, Zund G, Cheng S, Melnitchouk S, Kadner A, Sodian R, Kolb SA, Turina M. A new approach to completely autologous cardiovascular tissue in humans. ASAIO J. 2002 May-Jun; 48(3): 234-8.

70. Niklason LE. Techview: medical technology. Replacement arteries made to order. Science. 1999 Nov 19; 286(5444): 1493-4.

71. Stock UA, Mayer JE Jr. Tissue engineering of cardiac valves on the basis of PGA/PLA Co-polymers. J Long Term Eff Med Implants. 2001; 11(3-4): 249-60.

72. Mayer JE Jr, Shin'oka T, Shum-Tim D. Tissue engineering of cardiovascular structures. Curr Opin Cardiol. 1997 Nov; 12(6): 528-32.

73. Nugent HM, Edelman ER. Tissue engineering therapy for cardiovascular disease. Circ Res. 2003 May 30; 92(10): 1068-78. Review.

[Seite 54↓]

74. Mitchell SL, Niklason LE. Requirements for growing tissue-engineered vascular grafts. Cardiovasc Pathol. 2003 Mar-Apr; 12(2): 59-64.

75. Teebken OE, Puschmann C, Aper T, Haverich A, Mertsching H. Tissue-engineered bioprosthetic venous valve: a long-term study in sheep. Eur J Vasc Endovasc Surg. 2003 Apr; 25(4): 305-12.

76. Thubrikar MJ, Nolan SP, Aouad J, Deck JD. Stress sharing between the sinus and leaflets of canine aortic valve. Ann Thorac Surg. 1986 Oct; 42(4): 434-40.

77. Brutel de la Riviere A, Quaegebeur JM, Hennis PJ, Bruteil de la Riviere G, Huysmans HA, Brom AG. Growth of an aorta-coronary anastomosis. An experimental study in pigs. J Thorac Cardiovasc Surg. 1983 Sep; 86(3): 393-9.

78. Kofidis T, Lenz A, Boublik J, Akhyari P, Wachsmann B, Mueller-Stahl K, Hofmann M, Haverich A. Pulsatile perfusion and cardiomyocyte viability in a solid three-dimensional matrix. Biomaterials. 2003 Dec; 24(27): 5009-14.

79. Ochoa ER, Vacanti JP. An overview of the pathology and approaches to tissue engineering. Ann N Y Acad Sci. 2002 Dec; 979: 10-26; discussion 35-8. Review.

80. Mol A, Bouten CV, Zund G, Gunter CI, Visjager JF, Turina MI, Baaijens FP, Hoerstrup SP. The relevance of large strains in functional tissue engineering of heart valves. Thorac Cardiovasc Surg. 2003 Apr; 51(2): 78-83.

81. Barron V, Lyons E, Stenson-Cox C, McHugh PE, Pandit A. Bioreactors for cardiovascular cell and tissue growth: a review. Ann Biomed Eng. 2003 Oct; 31(9): 1017-30. Review.

82. Heikkinen LO, Jarvinen AA. Aortopulmonary fistula after coarctation repair with Dacron patch aortoplasty. Ann Thorac Surg. 2002 May; 73(5): 1634-6.

83. Stamm C, Kreutzer C, Zurakowski D, Nollert G, Friehs I, Mayer JE, Jonas RA, del Nido PJ. Forty-one years of surgical experience with congenital supravalvular aortic stenosis. J Thorac Cardiovasc Surg. 1999 Nov; 118(5): 874-85.

84. Vacanti JP, Langer R. Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet. 1999 Jul; 354 Suppl 1: SI32-4.

85. Langer RS, Vacanti JP. Tissue engineering: the challenges ahead. Sci Am. 1999 Apr; 280(4): 86-9.

86. Zisch AH, Lutolf MP, Hubbell JA. Biopolymeric delivery matrices for angiogenic growth factors. Cardiovasc Pathol. 2003 Nov-Dec; 12(6): 295-310.

[Seite 55↓]

87. Dvorin EL, Wylie-Sears J, Kaushal S, Martin DP, Bischoff J. Quantitative evaluation of endothelial progenitors and cardiac valve endothelial cells: proliferation and differentiation on poly-glycolic acid/poly-4-hydroxybutyrate scaffold in response to vascular endothelial growth factor and transforming growth factor beta1. Tissue Eng. 2003 Jun; 9(3): 487-93.

88. Sutherland FW, Perry TE, Nasseri BA, Wang J, Kaushal S, Guleserian KJ, Martin DP, Vacant JP, Mayer JE Jr. Advances in the mechanisms of cell delivery to cardiovascular scaffolds: comparison of two rotating cell culture systems. ASAIO J. 2002 Jul-Aug; 48(4): 346-9.

89. Martin I, Wendt D, Heberer M. The role of bioreactors in tissue engineering. Trends Biotechnol. 2004 Feb; 22(2): 80-6.

90. Langer R. Tissue engineering. Mol Ther. 2000 Jan; 1(1): 12-5.

91. Agrawal CM, McKinney JS, Lanctot D, Athanasiou KA. Effects of fluid flow on the in vitro degradation kinetics of biodegradable scaffolds for tissue engineering. Biomaterials. 2000 Dec; 21(23): 2443-52.

© Die inhaltliche Zusammenstellung und Aufmachung dieser Publikation sowie die elektronische Verarbeitung sind urheberrechtlich geschützt. Jede Verwertung, die nicht ausdrücklich vom Urheberrechtsgesetz zugelassen ist, bedarf der vorherigen Zustimmung. Das gilt insbesondere für die Vervielfältigung, die Bearbeitung und Einspeicherung und Verarbeitung in elektronische Systeme.
DiML DTD Version 4.0Zertifizierter Dokumentenserver
der Humboldt-Universität zu Berlin
HTML-Version erstellt am: